Clinical Trials Directory

Trials / Completed

CompletedNCT03126201

Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis

Predictors of Disease Progression in Patients With Primary Focal Segmental Glomerulosclerosis

Status
Completed
Phase
Study type
Observational
Enrollment
86 (actual)
Sponsor
Istanbul University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Focal segmental glomerulosclerosis (FSGS) is one of the most common primary glomerular diseases leading to end stage renal disease. In this study, our aim is to evaluate the effects of histopathological, clinical, and laboratory features of patients with primary FSGS on the disease progression.

Detailed description

Focal segmental glomerulosclerosis (FSGS) is one of the most common primary glomerular diseases leading to end stage renal disease worldwide. Numerous studies have been conducted in order to identify the etiology of this debilitating disease. Beyond the etiological research, however, few studies managed to demonstrate the possible predictors of disease progression in patients. Therefore, we aim to evaluate the effects of histopathological, clinical, and laboratory features of patients with primary FSGS on the disease progression.

Conditions

Timeline

Start date
2016-12-01
Primary completion
2017-09-01
Completion
2017-11-01
First posted
2017-04-24
Last updated
2018-02-19

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03126201. Inclusion in this directory is not an endorsement.